4D Molecular Therapeutics Inc (FDMT) USD0.0001

Sell:$3.33Buy:$3.34$0.09 (2.77%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.33
Buy:$3.34
Change:$0.09 (2.77%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$3.33
Buy:$3.34
Change:$0.09 (2.77%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.

Key people

John F. Milligan
Executive Chairman of the Board
Fariborz Kamal
President, Chief Operating Officer
David Kirn
Chief Executive Officer, Co-Founder, Director
Uneek Mehra
Chief Financial and Business Officer
Robert Kim
Chief Medical Officer
Scott Bizily
Chief Legal Officer and Corporate Secretary
Jacob M. Chacko
Independent Director
Susannah Gray
Independent Director
Nancy Miller-Rich
Independent Director
Charles P. Theuer
Independent Director
Shawn Cline Tomasello
Independent Director
Click to see more

Key facts

  • EPIC
    FDMT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US35104E1001
  • Market cap
    $158.35m
  • Employees
    227
  • Shares in issue
    46.30m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.